Antares Pharma

Bucking the trend, Antares gains FDA OK for testosterone rejection on second try
Bucking the trend, Antares gains FDA OK for testosterone rejection on second try
Endpoints
Antares Pharma
XYOSTED
testosterone
FDA
Flag link:
Pfizer Is Keeping Details of New 'Rescue Pen' Low Key, for Now
Pfizer Is Keeping Details of New 'Rescue Pen' Low Key, for Now
Medical Devices and Diagnostics Industry
Antares Pharma
Pfizer
QuickShot autoinjector
drug delivery
drug development
Flag link:
Teva and Antares Pharma Announce Launch of Generic Imitrex® in the United States
Teva and Antares Pharma Announce Launch of Generic Imitrex® in the United States
Yahoo
Teva Pharmaceutical
Antares Pharma
generics
Imitrex
migraines
Flag link:
Antares Pharma announces notice of allowance for new patent
Antares Pharma announces notice of allowance for new patent
The Fly on the Wall
patents
devices
Antares Pharma
injectables
Flag link:
Antares Pharma Announces the Issuance of a New U. S. Patent for OTREXUP™
Antares Pharma Announces the Issuance of a New U. S. Patent for OTREXUP™
Yahoo/BusinessWire
Antares Pharma
patent
devices
Flag link:
A Deep Dive Into Antares Pharma's Buyout Thesis
A Deep Dive Into Antares Pharma's Buyout Thesis
Seeking Alpha
Antares Pharma
Pfizer
Flag link:
3 Things to Watch With Antares Pharma
3 Things to Watch With Antares Pharma
Motley Fool
Antares Pharma
Vibex MTX
Teva
Ferring
Flag link:
Antares Pharma Announces Positive Results from Final MTX Medi-Jet™ Clinical Study
Antares Pharma Announces Positive Results from Final MTX Medi-Jet™ Clinical Study
Antares Pharma
Medi-jet
clinical trials
research
Flag link:
Antares Pharma aims to raise $47M from stock sale
Antares Pharma aims to raise $47M from stock sale
Antares Pharma
stock
funding
Flag link:
Reconsidering Zalicus And Antares In Light Of Shakeups
Reconsidering Zalicus And Antares In Light Of Shakeups
Seeking Alpha
Zalicus
Antares Pharma
Acadia
Novartis
Pfizer
Sanofi
Flag link:
Antares Pharma says it will sell stock to raise research funds; gets $750K payment from Pfizer
Antares Pharma says it will sell stock to raise research funds; gets $750K payment from Pfizer
Yahoo/AP
Pfizer
Antares Pharma
stock offering
Vibex QST gel
Flag link:
Antares Pharma Announces Successful Results from VIBEX MTX Actual Human Use Study
Antares Pharma Announces Successful Results from VIBEX MTX Actual Human Use Study
Antares Pharma
VIBEX
research
Flag link:
Antares Pharma Reports Second Quarter 2012 Financial and Operating Results
Antares Pharma Reports Second Quarter 2012 Financial and Operating Results
Antares Pharma
earnings
Flag link:
Antares Pharma Announces Positive Results from VIBEX MTX Usability Study
Antares Pharma Announces Positive Results from VIBEX MTX Usability Study
Antares Pharma
VIBEX
research
Flag link:
Antares Pharma Announces Move to the NASDAQ Stock Market
Antares Pharma Announces Move to the NASDAQ Stock Market
Antares Pharma
NASDAQ
stock
Flag link:
Antares Pharma Reports First Quarter 2012 Financial and Operating Results
Antares Pharma Reports First Quarter 2012 Financial and Operating Results
Antares Pharma
earnings
Flag link:
Watson, Antares launch Gelnique 3% for overactive bladder treatment
Watson, Antares launch Gelnique 3% for overactive bladder treatment
Pharmabiz
Watson Pharmaceuticals
Antares Pharma
Gelnique
overactive bladder
Flag link:
Antares Pharma and Boston Scientific Look to Make Headway in Surging Medical Supplies Industry
Antares Pharma and Boston Scientific Look to Make Headway in Surging Medical Supplies Industry
Antares Pharma
Boston Scientific
supply
Flag link:
Antares Pharma Reports Fourth Quarter and Full Year 2011 Financial and Operating Results
Antares Pharma Reports Fourth Quarter and Full Year 2011 Financial and Operating Results
Antares Pharma
earnings
Flag link:
Bio-Pharma Watch List: 2 Week Report Card
Bio-Pharma Watch List: 2 Week Report Card
Seeking Alpha
Spectrum Pharmaceuticals
Acadia
Antares Pharma
BioSante
Indenix
Flag link:

Pages